SCIENCE AND INNOVATION
Discover how we work with leading researchers and academic groups to innovate and bring the best science to HIV treatment, prevention and care...
With modern advancements in HIV medicines and care, people living with HIV can live as long as people without. But unfortunately, HIV stigma is still prevalent. That’s why we are using virtual reality to put HCPs in the shoes of people living with HIV.
In this article by Professor José Gatell, he shares his insights on what multidrug-resistance HIV is and his insights on how to manage such a complex condition.
Thanks to advances in science and innovation, people living with HIV have options for effective treatment that mean they can expect to live long and healthy lives. Find out why understanding the needs and wants of people living with HIV is essential.
COMMITMENT TO GLOBAL HEALTH
Explore our work with NGOs, HCPs, regulatory authorities, HIV clinics and the wider medical community to help ensure people living with HIV get the most effective care globally…
The latest global statistics from UNAIDS, state that 1.7 million children are currently living with HIV and only half of those children with HIV have access to treatment, compared with 68% of adults.
HIV may not be the first thing that comes to mind when you think about Latin America, but together with the Caribbean, the region is home to an estimated 2.1 million people living with HIV.
One country that’s making headway in the fight against HIV is Botswana, where 360,000 people living with HIV (PLHIV) live. This is despite outstanding achievements in addressing gaps in HIV treatment and care in the country.
COMMUNITY ENGAGEMENT
Find out how we're partnering with communities across the world to fight HIV stigma and support people living with HIV...
When discussing people engaging in chemsex, it is crucial that we approach the topic with a pro-pleasure and sex-positive mentality that is free of judgement. This is key to creating a safe and healthy environment that enables people to participate in consensual and fulfilling sexual experiences.
In this article, Mercy Shibemba shares her hopes and aspirations for the future. She reflects on how living with HIV shaped her childhood and how her concept of healthy living may shift as she gets older.
In this article, Garry Brough shares his personal experience of ageing with HIV and his thoughts with respect to improving quality of life and the role that treatment can play, along with some key advice that we would share with his younger self and other people living with HIV.
POSITIVE PERSPECTIVES RESEARCH
Read about the experiences of people living with HIV with explanation and segmentation of data from the Positive Perspectives - Waves 1 and 2 studies. Positive Perspectives is one of the largest, global, HIV patient-reported outcomes studies to date...
It is now established that if you’re on treatment and have an undetectable viral load, you cannot pass on HIV through sex. Undetectable = Untransmittable, or U=U. This simple equation has profound implications for everyone living with HIV, and for economies and governments around the world.
Hear from Garry Brough, who draws on insights from the Positive Perspectives 2 study, on the complex relationship of ageing with HIV, the importance of optimising ones treatment options and the value of focusing on the needs of the individual.
The Global Positive Perspectives Wave 2 Study is one of the largest, global, HIV patient-reported outcomes studies to date, involving 2,389 people living with HIV (PLHIV) aged 18-84 across 25 countries.
NP-GBL-HVX-COCO-220070 | March 2024
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.
